Summary
A new cancer vaccine using tiny particles helped stop tumors in mice. The vaccine prevented the spread of melanoma, pancreatic, and triple-negative breast cancers, keeping many mice tumor-free. The study was done by scientists from the University of Massachusetts Amherst.
Key Facts
- The vaccine targets melanoma, pancreatic, and triple-negative breast cancers in mice.
- 88% of vaccinated mice stayed tumor-free, depending on the cancer type.
- The vaccine works by activating the immune system to fight cancer.
- The nanoparticles help the immune system recognize and attack cancer cells.
- In tests, "super adjuvant" vaccinated mice survived 250 days, while others did not survive past 35 days.
- The vaccine also stopped cancer from spreading to the lungs in mice.
- Researchers plan to develop this technology into a therapeutic vaccine for humans.
- Further studies are needed to see if the results work for people.
